Results

Total Results: 2,463 records

Showing results for "testing".

161. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
     March 17, 2020 - Manufacturers of FDA regulated devices typically are required to demonstrate, through testing, that … If there are no such technologies, then we will expand this testing to include any technologies that … Data Synthesis Direct (hands on) usability and performance testing will be restricted to those … If there are no such technologies, then we will expand this testing to include any technologies … The team realized that the original proposed approach to direct usability and performance testing

162. Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems Decisionmakers (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-usability-testing.pdf
     November 01, 2018 - Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems Decisionmakers … Methods Research Report Development and Usability Testing of EPC Evidence … Summaries for Health Systems Decisionmakers Methods Research Report Development and Usability Testing … Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems … We modified the interview guide and format of the interview substantially following pilot testing, in

163. Management of Infantile Epilepsy | Effective Health Care Program
     effectivehealthcare.ahrq.gov/webform/products/management-infantile-epilepsy/submit-sead
     April 05, 2021 - Leave this field blank CAPTCHA This question is for testing whether or not you are a human visitor

164. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
     June 01, 2012 - Preventive lipid testing in individuals with cardiovascular disease has changed the proportion able to … to treatment, and variable ordering of testing across subjects. … Resources for conventional Pap smear testing were strained at the time, which contributed to the rise … The underlying incidence and prevalence data included: Provided context Informed modeling of testing … impact Reviewers could not estimate the usefulness of human papilloma virus testing among older women

165. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
     June 01, 2012 - Preventive lipid testing in individuals with cardiovascular disease has changed the proportion able to … to treatment, and variable ordering of testing across subjects. … Resources for conventional Pap smear testing were strained at the time, which contributed to the rise … The underlying incidence and prevalence data included: Provided context Informed modeling of testing … impact Reviewers could not estimate the usefulness of human papilloma virus testing among older women

166. Disposition of Comments Report for Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_disposition-comments.pdf
     January 01, 2011 - However, considerable heterogeneity is likely to exist between testing platforms/methods, especially … We agree that considerable heterogeneity likely exists between testing platforms, and thus have added … The bundling of dialysis reimbursement has caused most providers to curtail lab testing, which may … Testing needs are different when clinical question is too much versus too little iron. … Testing needs are different when clinical question is too much vs. too little iron.

167. Maternal and Childhood Outcomes associated with the Special Supplemental Nutrition Program for Women, Infants and Children (WIC) | Effective Health Care Program
     effectivehealthcare.ahrq.gov/webform/products/outcomes-nutrition/submit-sead
     January 15, 2021 - Leave this field blank CAPTCHA This question is for testing whether or not you are a human visitor and

168. Disposition of Comments for PCA3 Testing for the Diagnosis and Management of Prostate Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
     April 01, 2013 - Disposition of Comments for PCA3 Testing for the Diagnosis and Management of Prostate Cancer Comparative … Effectiveness Research Review Disposition of Comments Report Research Review Title: PCA3 Testing … PCA3 Testing for the Diagnosis and Management of Prostate Cancer. … None of the included studies had men enrolled due to results of PCA3 testing. … TEP # 11 General I read the report "PCA3 testing for ... " with interest.

169. Version 2_Risk of Reinfection From SARS-CoV-2 -- An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
     December 31, 2022 - antibody levels, SARS-CoV-2 variants, or case identification method (e.g., surveillance, symptomatic testing … Antibody testing has been proposed as a potential marker or correlate of protection against infection … In these situations, the prognostic value of antibody testing was identical to the prognostic value … settings when the timing of testing in relation to infection is unknown. … Re- infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing.

170. celiac-disease-protocol-140612 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/celiac-disease_research-protocol.pdf
     June 12, 2014 - The validity and acceptability of the various diagnostic testing regimens and criteria have remained … Finally, in response to a comment about how previously negative testing affects test accuracy, we added … c- length of time ingesting gluten before diagnostic testing? … , including race, genetics, geography, SES e- Patients with IgA deficiency f- Patients previously testing … Positive and negative likelihood ratios • For KQ 1b, for Clinical decision-making o Additional testing

171. Postpartum Care for Women up to One Year After Birth | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/postpartum-care-one-year/draft-comments
     August 12, 2021 - including lay support or outreach workers such as community health workers Laboratory facilities, such as testing … use/LARC placement Postpartum visit attendance Counseling Adherence to screening or laboratory testing … such as blood pressure measurement or glucose tolerance testing   Harms :     Health inequity … use/LARC placement Postpartum visit attendance Counseling Adherence to screening or laboratory testing … such as blood pressure measurement or glucose tolerance testing     Maternal health outcomes ,

172. Evaluation and Treatment of Cryptorchidism | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/undescended-testicle/research
     December 11, 2012 - Two studies for a total of 44 boys accurately predicted anorchia using hormonal stimulation testing. … Hormonal stimulation testing may predict anorchia, but evidence is insufficient, with only two studies

173. Thyroid Tests | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/thyroid-tests/

174. Diagnosis and Treatment of Clinical Alzheimer's-type Dementia (CATD) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/alzheimers-type-dementia/protocol
     November 27, 2018 - Neuropsychological testing may quantify the severity of cognitive impairment and the pattern of cognitive … However, access to comprehensive neuropsychological testing is limited in many clinical settings. … Currently there are no evidence-based guidelines about the merits of either brief cognitive testing or … comprehensive neuropsychological testing in this patient population. … Additional diagnostic testing outcomes will be considered for SOE grading when available data allow.

175. Diagnosis and Treatment of Clinical Alzheimer's-type Dementia (CATD) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
     November 02, 2018 - Neuropsychological testing may quantify the severity of cognitive impairment and the pattern of cognitive … However, access to comprehensive neuropsychological testing is limited in many clinical settings. … Currently there are no evidence-based guidelines about the merits of either brief cognitive testing … or comprehensive neuropsychological testing in this patient population. … Additional diagnostic testing outcomes will be considered for SOE grading when available data allow.

176. A Decisionmaking Tool for You and Your Health Care Professional (pdf file)
     effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-patient-encounter.pdf
     March 01, 2016 - Professional If you have smoked for many years, you may want to think about lung cancer screening (testing … HARM: False alarms and unneeded additional testing A false alarm happens when a person has a positive … HARM: Radiation Exposure This includes radiation from screening plus radiation from additional testing

177. A Decisionmaking Tool for You and Your Health Care Professional (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/lung-cancer-screening-patient-encounter.pdf
     March 01, 2016 - Professional If you have smoked for many years, you may want to think about lung cancer screening (testing … HARM: False alarms and unneeded additional testing A false alarm happens when a person has a positive … HARM: Radiation Exposure This includes radiation from screening plus radiation from additional testing

178. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
     January 24, 2022 - , N (%) Comorbidities, N (%) Assay Type Assay Brand Definition of a positive test Frequency of Ab testing … over the course of the study 05/2020 - 01/2021 Unvacinated, recovered individuals who had a history of testing … stratified, N (%) Male Sex/Gender, N (%) Comorbidities, N (%) Assay Type Assay Brand Frequency of Ab testing … Qatar with RT-PCR test results Centralized and standardized national anti-SARS-CoV-2 serological testing … every 2 weeks; Antibody testing every 4 weeks; Questionnaires re symptoms and exposures every 2 weeks

179. Methods Guide for Medical Test Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-bias_methods.pdf
     July 01, 2012 - don’t know status” are excluded and do not have their disease status verified (no reference standard testing … Relatives who are DECEASED are excluded from having any verification undertaken (no reference standard testing … Relatives who are UNABLE TO PARTICIPATE in interviews or further clinical testing are excluded from … having any verification method (no reference standard testing).

180. Testing the Predictive Validity of Strength of Evidence Grades | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/grades-predictive-values/abstract
     September 14, 2015 - Testing the Predictive Validity of Strength of Evidence Grades Abstract September 14, 2015